{"latest_checked": "2026-07-31T11:11:49.297005+00:00", "coverage_count": 5079, "recent_count": 17, "transaction_limit": 160, "filters": {"q": "", "ticker": "CRNX", "sector": "", "industry": "", "side": "", "start": "2026-06-16", "end": "2026-07-31"}, "summary": {"total": 17, "acquisition_count": 14, "disposal_count": 3, "acquisition_value": 0.0, "acquisition_value_label": "$0", "disposal_value": 366142.8, "disposal_value_label": "$366.1K", "net_value": -366142.8, "net_value_label": "$-366.1K", "flow_tone": "negative", "largest_value_label": "$224.1K", "top_sector": "Healthcare", "window_label": "16 Jun 2026 to 31 Jul 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 17, "value": "366142.8000", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$366.1K"}], "days": [{"transaction_date": "2026-06-17", "acquisitions": 0, "disposals": 2, "total": 2, "bar_width": 14.3}, {"transaction_date": "2026-06-18", "acquisitions": 14, "disposals": 0, "total": 14, "bar_width": 100.0}, {"transaction_date": "2026-07-02", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 7.1}], "side_mix": {"acquisitions": 14, "disposals": 3, "acquisition_share": 82.4, "disposal_share": 17.6}}, "company_flows": [{"symbol": "CRNX", "name": "Crinetics Pharmaceuticals Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-02", "acquisitions": 14, "disposals": 3, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 366142.8, "disposed_value_label": "$366.1K", "net_value": -366142.8, "net_value_label": "$-366.1K", "acquisition_share": 82.4, "disposal_share": 17.6, "detail_url": "https://sharemaestro.com/insider-activity/company/crnx/", "research_links": {"chart": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/", "report": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/report/", "factor": "/factors/ticker/6d6e93de-74e7-4867-9dbf-c398d509205c/"}}], "company_overview": [{"symbol": "CRNX", "name": "Crinetics Pharmaceuticals Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-02", "filings": 17, "acquisitions": 14, "disposals": 3, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 366142.8, "disposed_value_label": "$366.1K", "net_value": -366142.8, "net_value_label": "$-366.1K", "acquisition_share": 82.4, "disposal_share": 17.6, "tone": "Net acquisition", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/crnx/", "research_links": {"chart": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/", "report": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/report/", "factor": "/factors/ticker/6d6e93de-74e7-4867-9dbf-c398d509205c/"}}], "transactions": [{"symbol": "CRNX", "name": "Crinetics Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-02", "executive": "VIVALDI, COELHO ROGERIO", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 3000.0, "share_price": 40.0, "transaction_value": 120000.0, "fetched_at": "2026-07-23T21:57:45.200091+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/crnx/", "research_links": {"chart": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/", "report": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/report/", "factor": "/factors/ticker/6d6e93de-74e7-4867-9dbf-c398d509205c/"}}, {"symbol": "CRNX", "name": "Crinetics Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "BEDROSIAN, CAMILLE L", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 9730.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:31:17.849419+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/crnx/", "research_links": {"chart": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/", "report": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/report/", "factor": "/factors/ticker/6d6e93de-74e7-4867-9dbf-c398d509205c/"}}, {"symbol": "CRNX", "name": "Crinetics Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "BEDROSIAN, CAMILLE L", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 5925.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:31:17.848046+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/crnx/", "research_links": {"chart": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/", "report": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/report/", "factor": "/factors/ticker/6d6e93de-74e7-4867-9dbf-c398d509205c/"}}, {"symbol": "CRNX", "name": "Crinetics Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "DEARDORF, CAREN", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 5925.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:31:17.827152+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/crnx/", "research_links": {"chart": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/", "report": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/report/", "factor": "/factors/ticker/6d6e93de-74e7-4867-9dbf-c398d509205c/"}}, {"symbol": "CRNX", "name": "Crinetics Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "DEARDORF, CAREN", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 9730.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:31:17.837908+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/crnx/", "research_links": {"chart": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/", "report": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/report/", "factor": "/factors/ticker/6d6e93de-74e7-4867-9dbf-c398d509205c/"}}, {"symbol": "CRNX", "name": "Crinetics Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "FUST, MATTHEW K", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 9730.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:31:17.842488+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/crnx/", "research_links": {"chart": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/", "report": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/report/", "factor": "/factors/ticker/6d6e93de-74e7-4867-9dbf-c398d509205c/"}}, {"symbol": "CRNX", "name": "Crinetics Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "FUST, MATTHEW K", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 5925.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:31:17.841100+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/crnx/", "research_links": {"chart": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/", "report": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/report/", "factor": "/factors/ticker/6d6e93de-74e7-4867-9dbf-c398d509205c/"}}, {"symbol": "CRNX", "name": "Crinetics Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "NICHOLS, WESTON", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 5925.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:31:17.843978+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/crnx/", "research_links": {"chart": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/", "report": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/report/", "factor": "/factors/ticker/6d6e93de-74e7-4867-9dbf-c398d509205c/"}}, {"symbol": "CRNX", "name": "Crinetics Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "NICHOLS, WESTON", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 9730.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:31:17.839572+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/crnx/", "research_links": {"chart": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/", "report": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/report/", "factor": "/factors/ticker/6d6e93de-74e7-4867-9dbf-c398d509205c/"}}, {"symbol": "CRNX", "name": "Crinetics Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "OKEY, STEPHANIE", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 5925.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:31:17.833946+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/crnx/", "research_links": {"chart": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/", "report": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/report/", "factor": "/factors/ticker/6d6e93de-74e7-4867-9dbf-c398d509205c/"}}, {"symbol": "CRNX", "name": "Crinetics Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "OKEY, STEPHANIE", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 9730.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:31:17.836272+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/crnx/", "research_links": {"chart": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/", "report": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/report/", "factor": "/factors/ticker/6d6e93de-74e7-4867-9dbf-c398d509205c/"}}, {"symbol": "CRNX", "name": "Crinetics Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "VIVALDI, COELHO ROGERIO", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 9730.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:31:17.846600+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/crnx/", "research_links": {"chart": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/", "report": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/report/", "factor": "/factors/ticker/6d6e93de-74e7-4867-9dbf-c398d509205c/"}}, {"symbol": "CRNX", "name": "Crinetics Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "VIVALDI, COELHO ROGERIO", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 5925.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:31:17.845325+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/crnx/", "research_links": {"chart": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/", "report": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/report/", "factor": "/factors/ticker/6d6e93de-74e7-4867-9dbf-c398d509205c/"}}, {"symbol": "CRNX", "name": "Crinetics Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "WIERENGA, WENDELL", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 5925.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:31:17.850732+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/crnx/", "research_links": {"chart": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/", "report": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/report/", "factor": "/factors/ticker/6d6e93de-74e7-4867-9dbf-c398d509205c/"}}, {"symbol": "CRNX", "name": "Crinetics Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "WIERENGA, WENDELL", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 9730.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:31:17.852125+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/crnx/", "research_links": {"chart": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/", "report": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/report/", "factor": "/factors/ticker/6d6e93de-74e7-4867-9dbf-c398d509205c/"}}, {"symbol": "CRNX", "name": "Crinetics Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-17", "executive": "OKEY, STEPHANIE", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 6292.0, "share_price": 35.62, "transaction_value": 224121.04, "fetched_at": "2026-07-13T10:31:17.853521+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/crnx/", "research_links": {"chart": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/", "report": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/report/", "factor": "/factors/ticker/6d6e93de-74e7-4867-9dbf-c398d509205c/"}}, {"symbol": "CRNX", "name": "Crinetics Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-17", "executive": "OKEY, STEPHANIE", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 608.0, "share_price": 36.22, "transaction_value": 22021.76, "fetched_at": "2026-07-13T10:31:17.854981+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/crnx/", "research_links": {"chart": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/", "report": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/report/", "factor": "/factors/ticker/6d6e93de-74e7-4867-9dbf-c398d509205c/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}